BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37330541)

  • 21. Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.
    Vojtechova Z; Sabol I; Salakova M; Smahelova J; Zavadil J; Turek L; Grega M; Klozar J; Prochazka B; Tachezy R
    BMC Cancer; 2016 Jul; 16():382. PubMed ID: 27377959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-129-5p inhibits anchorage-independent growth through silencing of ACTN1 and the ELK4/c-FOS axis in HPV-transformed keratinocytes.
    Huseinovic A; Xu M; Jaspers A; Bais B; Steenbergen RDM
    J Med Virol; 2024 Apr; 96(4):e29580. PubMed ID: 38566572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays.
    Dippmann C; Schmitz M; Wunsch K; Schütze S; Beer K; Greinke C; Ikenberg H; Hoyer H; Runnebaum IB; Hansel A; Dürst M
    Clin Epigenetics; 2020 Nov; 12(1):171. PubMed ID: 33176878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel MicroRNA signatures in HPV-mediated cervical carcinogenesis in Indian women.
    Sharma S; Hussain S; Soni K; Singhal P; Tripathi R; Ramachandran VG; Sharma S; Das S; Pillai B; Bharadwaj M
    Tumour Biol; 2016 Apr; 37(4):4585-95. PubMed ID: 26508022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole genome sequencing in high-grade cervical intraepithelial neoplasia patients from different ethnic groups in China.
    Wang J; Li M; Zhao L; Zhou B; Chen H; Duan F; Wang G
    Medicine (Baltimore); 2023 Nov; 102(45):e35953. PubMed ID: 37960754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Virus Genotypes in Machine Learning Diagnostic Prediction Models for Cervical Cancer in Women With High-Risk Human Papillomavirus Infection.
    Xiao T; Wang C; Yang M; Yang J; Xu X; Shen L; Yang Z; Xing H; Ou CQ
    JAMA Netw Open; 2023 Aug; 6(8):e2326890. PubMed ID: 37531108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
    Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
    Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical performance of the aptima HPV assay in 4196 women with positive high-risk HPV and ASC-US cytology: A large women hospital experience.
    Wang T; Pradhan D; Zhang H; Matsko J; Zhao C
    Diagn Cytopathol; 2021 Jan; 49(1):5-10. PubMed ID: 32857920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted RNA next generation sequencing analysis of cervical smears can predict the presence of hrHPV-induced cervical lesions.
    Andralojc KM; Elmelik D; Rasing M; Pater B; Siebers AG; Bekkers R; Huynen MA; Bulten J; Loopik D; Melchers WJG; Leenders WPJ
    BMC Med; 2022 Jun; 20(1):206. PubMed ID: 35676700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer.
    Verlaat W; Van Leeuwen RW; Novianti PW; Schuuring E; Meijer CJLM; Van Der Zee AGJ; Snijders PJF; Heideman DAM; Steenbergen RDM; Wisman GBA
    Epigenetics; 2018; 13(7):769-778. PubMed ID: 30079796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology.
    Rijkaart DC; Heideman DA; Coupe VM; Brink AA; Verheijen RH; Skomedal H; Karlsen F; Morland E; Snijders PJ; Meijer CJ
    J Clin Microbiol; 2012 Jul; 50(7):2390-6. PubMed ID: 22553244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.
    Bukowski A; Hoyo C; Hudgens MG; Brewster WR; Valea F; Bentley RC; Vidal AC; Maguire RL; Schmitt JW; Murphy SK; North KE; Smith JS
    Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1564-1571. PubMed ID: 35654413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
    Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPV Screening Test for the Detection of Precancerous Cervical Lesions and Cervical Cancer in Israeli Women.
    Feinberg T; Yehuda-Shnaidman E; Wolf T; Sandbank J; Segal J; Vaknin Z; Schejter E
    Acta Cytol; 2021; 65(6):494-500. PubMed ID: 34515031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
    van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
    Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus E7 protein detection as a method of triage to colposcopy of HPV positive women, in comparison to genotyping and cytology. Final results of the PIPAVIR study.
    Agorastos T; Chatzistamatiou K; Moysiadis T; Kaufmann AM; Skenderi A; Lekka I; Koch I; Soutschek E; Boecher O; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Boschetti Gruetzmacher E; Tsertanidou A; Angelis L; Maglaveras N; Jansen-Duerr P
    Int J Cancer; 2017 Aug; 141(3):519-530. PubMed ID: 28470689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular progression to cervical precancer, epigenetic switch or sequential model?
    Nedjai B; Reuter C; Ahmad A; Banwait R; Warman R; Carton J; Boer S; Cuzick J; Lorincz AT
    Int J Cancer; 2018 Oct; 143(7):1720-1730. PubMed ID: 29679470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.